Aurobindo Pharma Q2 net up 5.7% at Rs 235cr
Aurobindo Pharma's total income from operations increased by 27.6 percent to Rs 1,913.9 crore in the second quarter (Q2) of this fiscal compared to Rs 1,500.4 crore in the same period last fiscal.
November 08, 2013 / 15:29 IST
Aurobindo Pharma said its consolidated net profit rose 5.7 percent to Rs 235 crore for the second quarter ended September 30, 2013.
The Hyderabad-based firm posted a profit after tax of Rs 222.4 crore during July-September last year. The company's total income from operations increased by 27.6 percent to Rs 1,913.9 crore in the second quarter (Q2) of this fiscal compared to Rs 1,500.4 crore in the same period last fiscal, Aurobindo Pharma said in a statement. "The integrated business in generic formulations is auguring well to drive the operating performance of the company. We are also investing in specific new, differentiated products offerings such as Oncology, Hormones, Peptides and OTC business which we believe will complement our business in the coming years," Aurobindo Pharma managing director N Govindarajan said. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
